MBOT - Microbot Medical Inc logo

MBOT

Microbot Medical Inc

Microbot Medical Inc. develops robotic endoluminal surgery devices for minimally invasive procedures. Its products include LIBERTY, an endovascular robotic system for navigating vascular tools, and NovaCross, a technology for intraluminal revascularization.

โš•๏ธ Healthcare NASDAQ Listed 1992 $ USD
$1,000 invested 30 years ago โ†’$0today

Score Overview

1 Year
Scoreโ€”
Net Growth-8.14%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-25.63%
Net Trend20%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trend20%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-47.08%
Net Trend40%
Net Income Consistency
Rev Growthโ€”
Rev Trend10%
Revenue Consistency
20 Years
Score2.2
Net Growth24.99%
Net Trend45%
Net Income Consistency
Rev Growth13.09%
Rev Trend25%
Revenue Consistency
30 Years
Score
Net Growth-2.99%
Net Trend43%
Net Income Consistency
Rev Growth-98.52%
Rev Trend27%
Revenue Consistency
All Time
Score
Net Growth-42.12%
Net Trend41%
Net Income Consistency
Rev Growth-92.50%
Rev Trend29%
Revenue Consistency

See the full market ranking โ†’

Microbot Medical Inc fundamental performance

Between 2005 and 2025, revenue declined from $ 205.91K to $ 0.00 and net income went from -$ 11M to -$ 13M. Revenue increased in 5 of those 20 years; net income in 9.

Across Microbot Medical Inc's full reported history, from 1992 to 2025, revenue declined from $ 1M to $ 0.00 and net income went from -$ 10M to -$ 13M. Revenue increased in 29% of the years measured; net income in 41%.

Microbot Medical Inc currently holds a 20-year HDB Score of 2.2 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.74โ€”
1 Year2025-08-12
$ 3.12-44.39%
5 Years2021-08-12
$ 7.30-76.23%
10 Years2016-08-12
$ 49.95-96.53%
20 Years2006-08-11
$ 31.59K-99.99%
30 Years1996-08-12
$ 143.78K-100.00%
All Time1992-03-25
$ 157.95K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 105K-$ 14M$ 72M
2025$ 0.00-$ 13M$ 78M
2024$ 0.00-$ 11M$ 5M
2023$ 0.00-$ 10M$ 6M
2022$ 0.00-$ 13M$ 8M
2021$ 0.00-$ 11M$ 15M
2020$ 0.00-$ 9M$ 24M
2019$ 0.00-$ 7M$ 31M
2018$ 0.00-$ 7M$ 5M
2017$ 0.00-$ 7M$ 10M
2016$ 0.00-$ 9M$ 2M
2015$ 117K-$ 36M$ 12M
2014$ 1M-$ 32M$ 24M
2013$ 1M-$ 26M$ 30M
2012$ 1M-$ 28M$ 22M
2011$ 1M-$ 21M$ 16M
2010$ 1M-$ 25M$ 19M
2009$ 992.87K-$ 27M$ 38M
2008$ 231.73K-$ 29M$ 34M
2007$ 56.72K-$ 25M$ 36M
2006$ 92.85K-$ 18M$ 55M
2005$ 205.91K-$ 11M$ 34M
2004$ 141.03K-$ 15M$ 41M
2003$ 273.43K-$ 12M$ 13M
2002$ 415.38K-$ 10M$ 4M
2001$ 805.23K-$ 3M$ 13M
2000$ 74.3K-$ 11M$ 22M
1999$ 5M-$ 15M$ 4M
1998$ 8M-$ 12M$ 17M
1997$ 10M-$ 18M$ 15M
1996$ 7M-$ 13M$ 19M
1995$ 11M-$ 8M$ 9M
1994$ 1M-$ 16M$ 8M
1993$ 3M-$ 12M$ 8M
IPO1992$ 1M-$ 10M$ 6M

Explore beyond MBOT

You're looking at Microbot Medical Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies